recent advances in fertility regulation professor pc ho department of o&g university of hong...
TRANSCRIPT
![Page 1: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/1.jpg)
Recent Advances in Fertility Regulation
Professor PC Ho
Department of O&G
University of Hong Kong
![Page 2: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/2.jpg)
Condom or sheathEspecially useful when coitus occurs
infrequently and at irregular intervals
Some protection against venereal disease
Coincident use of spermicides advisable
![Page 3: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/3.jpg)
Intrauterine contraceptive deviceTwo types:
1. Inert e.g. Lippes
2. Bioactive e.g. copper T or 7 or levonorgestrel IUCD; need renewal every 3-5 years
![Page 4: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/4.jpg)
Advantages of IUD
1. Highly effective
2. Little motivation
3. Non-coitus-related
4. Local effect
5. 90% conceive within 1 year of removal
![Page 5: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/5.jpg)
New copper IUCD
Cu T 380 A
Cu T 220 CMultiload 250 & 375
Nova T
Prerferred over inert devices
![Page 6: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/6.jpg)
Advantages of new copper IUCDs1. Smaller and easier to
insert
2. Less side effects
3. Lower pregnancy rate
<1/HWY
![Page 7: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/7.jpg)
Complications of IUCD1. Expulsion
2. Bleeding
3. Pain
4. Perforation
5. Pelvic infection
6. Pregnancy
![Page 8: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/8.jpg)
BleedingMost common complication
requiring removal; may present with:
1. Increased menstrual flow
2. Longer periods
3. Intermenstrual bleeding
![Page 9: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/9.jpg)
Management of bleeding problems
1. May improve after several cycles2. NSAID3. Anti-fibrinolytic agents4. Oral iron5. Remove IUCD/Change to smaller
or LNG-IUCD
![Page 10: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/10.jpg)
IUCD & ectopic pregnancy1. Does not increase overall risk of
ectopic pregnancy
2. Protects against IU pregnancy better than ectopic
3. Increased ectopic to intrauterine pregnancy ratio
![Page 11: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/11.jpg)
Pelvic Inflammatory Disease
No significant increase in low risk women
IUCD related PID rare beyond 20 days
![Page 12: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/12.jpg)
Contraindications1. Active or recent P.I.D.
2. Known or suspected pregnancy
3. Undiagnosed abnormal vaginal bleeding
4. Suspected/confirmed genital tract malignancy
5. Congenital uterine abnormality or fibroids that prevent proper placement
![Page 13: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/13.jpg)
Levonorgestrel IUCD
• Contains levonorgestrel which is slowly released
• Highly effective – Pearl Index 0-0.2/HWY
• Ectopic preg rate – 0.02%/year
![Page 14: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/14.jpg)
Levonorgestrel IUCD• Reduces menstrual blood loss but
there is a higher incidence of intermenstrual bleeding/spottingAmenorrhoea 16.1%Spotting 8.9%Meno/metrorrhagia 7.6%
(Siven & Stern 1994)
![Page 15: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/15.jpg)
Levonorgestrel IUCD
• Incidence of PID lower than Nova-T
• Removal rates at 5 years due to PID–LNG 0.8/HWY–Nova T 2.2/HWY
» (Andersson et al 1994)
![Page 16: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/16.jpg)
Modern combined oral contraceptives
• combination of oestrogen and progestogen taken daily for 21 days followed by an interval of 7 days
• Oestrogen - Ethinyl oestradiol 20 to 30 ug per tablet
• Progestogens: levonorgestrel;gestodene; desogestrel
• Failure rate < 0.1/HWY
![Page 17: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/17.jpg)
OC pills - Side Effects
• Nausea & vomiting
• dizziness & headache
• breast tenderness
• fluid retention and weight gain
• Intermenstrual spotting/bleeding
– may disappear after a few cycles
![Page 18: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/18.jpg)
Major complications of OC
• Increased risk of thromboembolism, cardiovascular diseases (CVA and myocardial infarction)
• Slightly increased risk of breast cancer and liver tumours (controversial - cervical cancer)
• Jaundice and liver dysfunction
![Page 19: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/19.jpg)
COC - Absolute Contraindications
• Pregnancy
• Smoking in women over 35
• Past or present evidence of thromboembolic disorders
• Complicated valvular heart disease
• Focal migraine
• Liver tumours
![Page 20: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/20.jpg)
COC - Absolute contraindications
• Acute liver disease or cirrhosis
• DM with vascular complications including hypertension
• Moderate or severe hypertension with BP > 160/100 mm Hg
• Hypertension with vascular disease
![Page 21: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/21.jpg)
COC - Relative contraindications (Risks usually outweigh benefits)
• Mild hypertension 140-159/90-99 mm Hg
• History of hypertension when BP cannot be evaluated
• Chronic liver disease other than severe cirrhosis
• Symptomatic biliary tract disease
• Known hyperlipidaemia
![Page 22: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/22.jpg)
Benefits of COC (I)
Reduction in risk of ovarian cancer
Reduction in risk of endometrial cancer
Menstrual benefits : Reduction in amount of blood loss mid-cycle pain menstrual irregularity premenstrual tension and dysmenorrhoea
![Page 23: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/23.jpg)
Benefits of COC (II)
Reduction in PID
Protects against benign breast tumour
Possible benefits protection against ovarian cyst, uterine
fibroids and osteoporosis
Highly effective form of contraception and protects against ectopic pregnancy
![Page 24: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/24.jpg)
Third generation progestogens
Desogestrel
Gestodene
Norgestimate
Better lipid profiles
![Page 25: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/25.jpg)
Concerns on new progestogens
• Do they increase the risk of deep vein thrombosis?
• Results are controversial and some of the results are probably due to the bias in the studies
• On the whole low dose OC pills are very safe; even if there is an increase in risk with new progestogens, the risk is small
![Page 26: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/26.jpg)
Commonly asked questions
Are combined OC pills safe in women over the age of 35? Yes, if the woman is healthy and non-smoking
Can OC pills be used in women with uterine fibroids?Yes. OC pills do not induce growth of fibroids and may decrease bleeding in these women
(ACOG 2001)
![Page 27: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/27.jpg)
Commonly asked questions
Can OC pills be used in SLE? In general, progestin-only methods should be used. Combined OC pills may be considered if SLE is stable and inactive with no thrombosis, nephropathy or antiphospholipid antibodies (ACOG, 2001)
![Page 28: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/28.jpg)
Commonly asked questions
Can OC pills be used in women with fibrocystic breast changes, fibroadenoma, or a family history of breast cancer? Yes
Do women have to stop OC pills every few years?No
(ACOG 2001)
![Page 29: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/29.jpg)
Depomedroxyprogesterone acetate (DMPA)
Disadvantages
1. High incidence of amenorrhoea or menstrual irregularity
2. Weight gain
3. Slow return of fertility after discontinuation
Advantages
1. Convenient - one injection/3 months
2. Can be used in women with contraindications to oestrogens
![Page 30: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/30.jpg)
Monthly Injectables• Cyclofem – 25 mg DMPA amd 5 mg E2
cypionate• Mesigyna – 50 mg NET EN amd 5 mg E2
valerate• Perlutan – 150 mg
dihydroxyprogesterone acetophenide + 10 mg E2 enanthate
• Given monthly +/- 3 days
![Page 31: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/31.jpg)
Monthly injectables
• Highly effective with pregnancy rates <1/HWY
• More regular cycle patterns 60-70% have regular cycles (compared to less than 10% in women on DMPA)
• Cannot be used for women with contra-indications for oestrogens
![Page 32: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/32.jpg)
Progestogen implants
Capsules containing levonogrestrel implanted under skin
Low failure rate (<1/100WY)
Most common side effect: excessive bleeding and intermenstrual bleeding
Rapid return of fertility on removal
Minimal metabolic effects
![Page 33: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/33.jpg)
The Implanon rod
Rate-controlling membrane (0.06 mm)
Core: 40% EVA60% etonogestrel
Membrane: 100% EVA
Core 2 m m
40 m m
![Page 34: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/34.jpg)
(*Croxatto and Mäkäräinen, Contraception,1998,58,91S-97S) (**Sivin, Stud Fam Plann,1988,19,81-94)
Contraceptive efficacy
Implanon*
1-3 years
Norplant**
1st year
Norplant **
5th year
Cycles 73,429 157,729 10,855
Pregnancies 0 24 9
Pearl index 0(conf. int. 0.00-0.07)
0.2 1.1
![Page 35: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/35.jpg)
(Affandi B. Contraception 1998;58:99S-107S)
Bleeding patterns
Bleeding patternImplanon
(N=169)Norplant
(N=163) P values
Amenorrhea 20.8% 4.4% < 0.0001
Infrequent B-S 26.1% 21.4% 0.099
Frequent B-S 6.0% 3.5% 0.14
Prolonged B-S 11.8% 8.5% 0.074
![Page 36: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/36.jpg)
Complications (Comparative trials, meta-analysis)
Implanon
n/N %
Norplant
n/N %
Insertioncomplications 2/689 0.3 0/689 0
Removalcomplications 1/644 0.2 7/145 4.8
(Mascarenhas L. Contraception 1998:58:79S-83S.)
![Page 37: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/37.jpg)
Post-coital contraceptionEmergency -
intercourse unexpectedrapefailure of barrier methods
Regular - not a good method because of high failure rate and side effects
![Page 38: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/38.jpg)
Yuzpe regimen
2 tablets of OC pills(100 g EE 1 mg norgestrel)within 72 hours of coitusAnother 2 tablets 12 hours laterPregnancy rates 0.2% - 2.6%Nausea 50% Vomiting 20-25%
![Page 39: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/39.jpg)
Randomised comparison of Yuzpe regimen with LNG
Yuzpe LNG
No of subjects 424 410
Pregnancy rates
whole group 3.5% 2.9%
No further
coitus 2.7% 2.4%
Ho & Kwan 1993
![Page 40: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/40.jpg)
46.5
22.4 23.1
36.8
20.8
4.2
16.1
2.7
18.5
23.9
15.9
3.4
0
10
20
30
40
50
Nause
a
Vomiti
ng
Dizzin
ess
Fatigu
e
Breas
t ten
dernes
sIM
B
Inci
den
ce o
f si
de
effe
cts
(%) YUZPE
LNG
*
*
*
![Page 41: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/41.jpg)
Group Number ofGroup Number of Observed Observed Pregnancy Pregnancy womenwomen pregnancies rate (%) pregnancies rate (%) 95% CI 95% CI
YuzpeYuzpe 979 979 3131 3.23.2 (2.2, 4.5) (2.2, 4.5) LNG LNG 976 976 1111 1.11.1 (0.6, 2.0) (0.6, 2.0)
Relative risk (RR) of pregnancy for LNG compared with Yuzpe:Relative risk (RR) of pregnancy for LNG compared with Yuzpe:
RRRR 95% CI 95% CI
0.360.36 (0.18, 0.70)(0.18, 0.70) WHO 1998WHO 1998
*
Pregnancy ratesPregnancy rates
![Page 42: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/42.jpg)
50.5
18.8 20.216.7
28.5
23.1
5.6
16.8
11.2
16.9
0
10
20
30
40
50
60
Nausea Vomiting Headache Dizziness Fatigue
Inci
denc
e of
sid
e ef
fect
s (%
)YUZPELNG
*
**
*
![Page 43: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/43.jpg)
Pregnancy rates by further acts of intercourse
Further Acts of intercourse
No Yes
Yuzpe 1.9% 5.3%
LNG 0.8% 1.6%
![Page 44: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/44.jpg)
ConclusionsConclusions
• The LNG regimen is more effective than The LNG regimen is more effective than the Yuzpe regimen.the Yuzpe regimen.
• It is better tolerated.It is better tolerated.
• With both regimens, earlier treatment is With both regimens, earlier treatment is more effective.more effective.
![Page 45: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/45.jpg)
Mifepristone (RU 486)• Antiprogestin which blocks the
action of progesterone • Used in inducing abortions• Highly effective in emergency
contraception even at a very low dose (10 mg) which does not cause abortion
![Page 46: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/46.jpg)
Post-coital insertion ofCopper I.U.C.D.
Advantages:
1. Highly effective pregnancy rate
<0.1%
2. Can be used 5 days after intercourse
3. Continued contraception
Disadvantages:
Bleeding; pain; infection
![Page 47: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/47.jpg)
Emergency Contraception
1. Effective and safe methods are now available but they are underutilized
2. Need to remove barriers- Education- Improve access
![Page 48: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/48.jpg)
TOP in first trimester1. Surgical methods
Suction evacuation
2. Medical method (<9 wks)
Mifepristone (RU486) + PG
![Page 49: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/49.jpg)
Regimen of medical abortion with mifepristone and PG analogue
Mifepristone PG analogue Follow up
48h
2 weeks
![Page 50: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/50.jpg)
Medical abortion with mifepristone & PG
• For TOP up to 9 weeks
• Misoprostol is commonly used now
• Complete abortion rate over 95%
• The process resembles miscarriage: abdominal pain, bleeding and expulsion of products of conception
![Page 51: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/51.jpg)
Complicationsof Sterilization1. Complications due to laparoscopy
or laparotomy - visceral damage; bleeding; wound complications including pain and infection
2. Failure (about 1 in 200 lifetime risk)
3. Ectopic pregnancy
Mortality rate 1 in 10,000
![Page 52: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/52.jpg)
VasectomyAdvantages
1. Simple and quick operation requiring less skill
2. Local anaesthesia
3. Less complication
4. Easier to reverse
Disadvantage
Not immediately effective - 2 negative semen tests at 8 and 12 weeks
![Page 53: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/53.jpg)
Long term health risks of vasectomy
Men can be reasssured that there is no substantial long-term health risk associated with vasectomy but they should be informed about the possibility of chronic testicular pain after vasectomy. The pain is generally mild and only rarely requires further medical or surgical intervention.
RCOG 1999
![Page 54: Recent Advances in Fertility Regulation Professor PC Ho Department of O&G University of Hong Kong](https://reader035.vdocuments.us/reader035/viewer/2022062714/56649d1f5503460f949f2d4f/html5/thumbnails/54.jpg)
Other new developments
• Hormonal patch
• Vaginal rings
• Male pills